Surgical Oncology
LEADERSHIP
Position:
Division Director
1100 Walnut Street
MOB, 5th Floor
Philadelphia, PA 19107
Email:
Nader.Hanna@jefferson.edu
Contact Number(s):
Research
Our faculty members publish in peer-reviewed journals, author book chapters and present frequently at local and national conferences.
Recent Publications
- Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms
- Consensus guideline for the management of peritoneal mesothelioma
- Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases
- Consensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement
- Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement
- Consensus guideline for the management of colorectal cancer with peritoneal metastases
- ACR Appropriateness Criteria® Colorectal Cancer Screening: 2024 Update
- Impact of Disease Etiology and Indication for Colectomy on Postoperative Outcomes: NSQIP Colectomy-Targeted Database Study
- Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused Update
- Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle-Invasive Bladder Cancer in the United States
- When Benchmarks Fail Us: A Case Study in Cytoreductive Surgery
- Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms
- Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases
- Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results from an International Multicenter Study
- ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer
- ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer
- MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways
- LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
- AJCC Cancer Staging System Version 9: Appendiceal Adenocarcinoma
- International Expert Consensus on Defining Textbook Oncologic Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis